AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. OPRX
  4. [SCHEDULE 13G/A] OptimizeRx Corporation SEC Filing

[SCHEDULE 13G/A] OptimizeRx Corporation SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Filing content is currently unavailable.

Source:

Stock OPRX logo
Optimizerx Corp

NASDAQ:OPRX

OPRX Rankings

#3669 Ranked by Market Cap
N/A Ranked by Dividends

OPRX Latest News

Sep 10, 2025
OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference
Sep 9, 2025
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
Aug 19, 2025
OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth
Aug 7, 2025
OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
Jul 30, 2025
Paynela Appoints Healthcare Technology Veteran William Febbo to Board of Directors

OPRX Latest SEC Filings

Aug 29, 2025
[144] OptimizeRx Corporation SEC Filing
Aug 25, 2025
[Form 4] OptimizeRx Corporation Insider Trading Activity
Aug 25, 2025
[Form 4] OptimizeRx Corporation Insider Trading Activity
Aug 25, 2025
[Form 4] OptimizeRx Corporation Insider Trading Activity
Aug 25, 2025
[Form 4] OptimizeRx Corporation Insider Trading Activity

OPRX Stock Data

339.55M
15.59M
14.93%
70.5%
6.13%
Health Information Services
Services-business Services, Nec
United States
WALTHAM